This is the authors' abstract. We don't add key points for this paper.
The relevance of anti-human leucocyte antigen (anti-HLA) antibodies in the outcome of organ transplantation has been recognized in the past 40 years. Detection of these antibodies in sensitized recipients plays a pivotal role in this issue. Flow cytometry analysis is one of the choice cell-based techniques together with the pioneer complementdependent cytotoxicity crossmatch. Here, we discuss the advantages and limits of these cell-based assays and their use in the clinical laboratory of immunology of transplantation. Moreover, we compared this approach to other beads-based detection assays introduced more recently in the laboratory practice.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Grimaldi et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: